First-line bevacizumab contributes to survival improvement in glioblastoma patients complementary to temozolomide

被引：0

作者：

Nobuhiro Hata

Masahiro Mizoguchi

Daisuke Kuga

Ryusuke Hatae

Yojiro Akagi

Yuhei Sangatsuda

Takeo Amemiya

Yuhei Michiwaki

Yutaka Fujioka

Kosuke Takigawa

Satoshi O. Suzuki

Tadamasa Yoshitake

Osamu Togao

Akio Hiwatashi

Koji Yoshimoto

Koji Iihara

机构：

[1] Kyushu University,Department of Neurosurgery, Graduate School of Medical Sciences

[2] Kyushu University,Department of Neuropathology, Graduate School of Medical Sciences

[3] Kyushu University,Department of Clinical Radiology, Graduate School of Medical Sciences

[4] Kagoshima University,Department of Neurosurgery, Graduate School of Medical and Dental Sciences

来源：

Journal of Neuro-Oncology | 2020年 / 146卷

关键词：

Bevacizumab; Glioblastoma; Radiotherapy; Survival; Temozolomide;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：451 / 458

页数：7

共 77 条